Sweden· SE-20240422000064
Vancomycin Bioglan 500 mg Pulver till koncentrat till infusionsvätska, lösning
A medicinal product containing vancomycin, registered in Sweden by Bioglan AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Vancomycin
- Manufacturer
- Bioglan AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20240422000064
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vancomycin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVANCOMYCIN APTAPHARMAApta Medica Internacional d.o.o., Ljubljana
- United KingdomVancocin 500mg powder for solution for infusion vialsFlynn Pharma Ltd
- FinlandNorimkoNRIM Limited
- BelgiumVamysin 500 mgTeva Pharma Belgium
- PolandEdicinSandoz GmbH
- IrelandVancocin 500 mg powder for concentrate for solution for infusion and powder for oral solutionFlynn Pharma Limited
- SwitzerlandVanco Labatec 500 mg, poudre pour solution à diluer pour perfusionLabatec Pharma SA
- SpainVANCOMICINA MIP 500 MG POLVO PARA SOLUCION PARA PERFUSION EFGMip Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Vancocin, Vancomycin Aptapharma
- Belgium · Vancomycine Fresenius Kabi, Vancomycine Sandoz
- Bulgaria · Vancocin Cp, Ванко-Вм
- Cyprus · Vanco, Vanco Sapiens
- Czechia · Cedepos, Edicin
- Germany · Vanco-Saar, Vancomycin "lederle"
- Denmark · Bactocin, Vancocin
- Estonia · Vancomycin Kabi, Vancosan
- Spain · Vancomicina Mip, Vancomicina Noridem
- Finland · Vancomycin Bioglan, Vancomycin Bioglan 500 Mg Pulver Till Koncentrat Till Infusionsvätska, Lösning
- France · Vancomycine Hikma, Vancomycine Kabi
- United Kingdom (Northern Ireland) · Vancocin, Vancocin Matrigel
- Greece · Lyovanco, Vancomycin Noridem
- Croatia · Edicin, Vancomicin Viatris
- Hungary · Vancocin, Vancomycin Aptapharma
- Ireland · Vancocin, Vancocin Matrigel
- Iceland · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Italy · Levovanox, Maxivanil
- Lithuania · Vancomycin Ibe, Vancomycin Kabi
- Luxembourg · Vancomycin Enterocaps, Vancomycine
- Latvia · Vancomycin Kabi, Vancosan
- Malta · Cedepos, Vancomycin Aptapharma
- Netherlands · Vancocin Cp, Vancomycine Fresenius Kabi
- Norway · Vancomycin Fresenius Kabi, Vancomycin Hameln
- Poland · Edicin, Vancomicina Reig Jofre
- Portugal · Vancomicina Azevedos, Vancomicina Generis
- Romania · Cedepos, Vancomicină Aptapharma
- Slovenia · Edicin, Vancomycin Viatris
- Slovakia · Cedepos, Edicin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/957df66b-471b-40fa-bf6c-05c209dd74c6 GET /v1/drugs/957df66b-471b-40fa-bf6c-05c209dd74c6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20240422000064",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240422000064",
"product_doc_link": "https://docetp.mpa.se/LMF/Vancomycin%20Bioglan%20powder%20for%20concentrate%20for%20solution%20for%20infusion%20SmPC_09001bee8414007c.pdf"
}See everything about vancomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.